Key result
Xin-Ke-Shu significantly reversed the over-expressions of PLA2 IIA, CaMK II, and Pro-Caspase-3 and regulated metabolic perturbations in isoproterenol-induced myocardial infarction rats.
Why the study?
Does Xin-Ke-Shu inhibit myocardium Ca2+ overloading and metabolic alterations in isoproterenol-induced myocardial infarction models?
Population
Isoproterenol (ISO)-induced myocardial infarction (MI) rats and H9c2 cells
Comparison
Xin-Ke-Shu pretreatment vs Normal control, ISO-induced MI model without…
Design
Preclinical
Authors
Loading...
Hypothesis-generating for Xin-Ke-Shu in isoproterenol-induced MI models; does not yet inform clinical practice.
Does Xin-Ke-Shu inhibit myocardium Ca2+ overloading and metabolic alterations in isoproterenol-induced myocardial infarction models?
p-value: p=<0.05
Xin-Ke-Shu protects against isoproterenol-induced myocardial infarction in preclinical models by inhibiting the Ca2+ overloading mechanism and regulating associated metabolic pathways.
Liu et al. (2016) studied Isoproterenol-induced myocardial infarction (n=24). Xin-Ke-Shu vs. Isoproterenol alone was evaluated on Expressions of PLA2 IIA, CaMK II and Pro-Caspase-3 (p=<0.05). Xin-Ke-Shu significantly reversed the over-expressions of PLA2 IIA, CaMK II, and Pro-Caspase-3 and regulated metabolic perturbations in isoproterenol-induced myocardial infarction rats.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: